Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVO.L Regulatory News (AVO)

  • There is currently no data for AVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

29 Jun 2023 13:35

RNS Number : 4207E
Advanced Oncotherapy PLC
29 June 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BD6SX109

Issuer Name

ADVANCED ONCOTHERAPY PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

ODEY ASSET MANAGEMENT LLP

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

28-Jun-2023

6. Date on which Issuer notified

29-Jun-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

7.490000

10.630000

18.120000

97973508

Position of previous notification (if applicable)

9.140000

10.680000

19.820000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BD6SX109

40473508

0

7.490000

0.000000

Sub Total 8.A

40473508

7.490000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Warrant

1 July 2026

Cash

18000000

3.330000

Warrant

30 march 2026

Cash

8000000

1.480000

Warrant

31 OCTOBER 2027

Cash

24000000

4.440000

Warrant

25 February 2025

Cash

7500000

1.390000

Sub Total 8.B2

57500000

10.630000%

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

none

12. Date of Completion

29-Jun-2023

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUKOUROOUNUAR
Date   Source Headline
8th Aug 20147:00 amRNSIssue of Equity and Warrants and director deal
25th Jul 201411:39 amRNSResult of AGM
25th Jul 20147:00 amRNSAGM Statement
22nd Jul 20147:00 amRNSNew Contract Signed with ScandiNova
16th Jul 201410:59 amRNSChange of Adviser
14th Jul 20147:00 amRNSContract Signed with global IT leader ICT
30th Jun 20141:16 pmRNSSector Reclassification
30th Jun 20147:00 amRNSFinal Results
23rd Jun 20147:00 amRNSAdvanced Oncotherapy Announce New American Entity
4th Jun 201411:19 amRNSHolding(s) in Company
2nd Jun 20147:00 amRNSAppointment of New CEO
20th May 20147:00 amRNSAVO features in CNY Business Journal
30th Apr 20147:01 amRNSDirector deals and Share Option Scheme
28th Apr 20147:00 amRNSAppointment of Director of Project Planning
17th Apr 201410:41 amRNSPLacing and Subscription
25th Mar 20147:00 amRNSConversion of Loan
10th Mar 20147:00 amRNSPresenting at National Proton Conference
20th Feb 20147:00 amRNSNew Board Appointment
6th Feb 20147:01 amRNSNew Medical Advisory Board Appointment
16th Jan 20147:00 amRNSChange of Nomad and Broker
9th Jan 20148:58 amRNSIssue of Equity
4th Dec 20137:00 amRNSCollider Exhibition at Science Museum
26th Nov 20137:00 amRNSAppointment of Bob Rose
22nd Nov 20137:00 amRNSAppointment of Executive Director
6th Nov 201312:08 pmRNSIssue of Equity
31st Oct 20137:00 amRNSDr Jay Loeffler Joins Medical Advisory Board
25th Oct 20137:00 amRNSBoard Changes
3rd Oct 20137:00 amRNSAppointment to Advisory Board and Issue of Equity
1st Oct 20137:00 amRNSAppointment of Director, Issue of Equity
25th Sep 20137:01 amRNSHalf Yearly Report
25th Sep 20137:00 amRNSAcquisition
18th Sep 20137:00 amRNSCollaboration Agreement
30th Aug 20137:15 amRNSDirectorate Change
23rd Aug 201312:14 pmRNSDirectorate Change
20th Aug 20137:00 amRNSCollaboration with Spire Healthcare
26th Jul 201312:17 pmRNSReplacement: Result of AGM
25th Jul 20135:37 pmRNSResult of AGM
19th Jul 201312:18 pmRNSHolding(s) in Company
10th Jul 20137:00 amRNSIssue of Equity
28th Jun 201312:23 pmRNSFinal Results
27th Jun 20137:00 amRNSIssue of Equity
4th Jun 201310:03 amRNSResult of Meeting
3rd Jun 20137:00 amRNSCollaboration with BMI Healthcare
16th May 20137:00 amRNSPosting of Circular
3rd May 20137:00 amRNSDirector Appointment
30th Apr 20137:00 amRNSHolding(s) in Company
26th Apr 201312:21 pmRNSDirector Dealing
26th Apr 20137:00 amRNSDirector Appointment
26th Apr 20137:00 amRNSDirector Dealing
25th Apr 20134:28 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.